2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the…
By G. Levine, E. Bates, J. Blankenship, S. Bailey, J. Bittl, B. Cercek, C. Chambers, S. Ellis, R. Guyton, S. Hollenberg and 8 more. Journal of the American College of Cardiology, 2011
2,553 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging, Surgery
View Paper: https://www.semanticscholar.org/paper/b1c8c7dca6d995bff649826481cc97323fc7f9ce
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Radiology, Nuclear Medicine and Imaging
In Surgery
Citations in the corpus
- 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013, methodology): “Quality metrics for both laboratory and operator performance and considerations with regard to primary PCI at hospitals without on-site cardiac surgery are reviewed in the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, Section 7.(219) Table 2.”
- 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014, background): “Proton pump inhibitors should be prescribed in patients with NSTE-ACS with a history of gastrointestinal bleeding who require triple antithrombotic therapy with a vitamin K antagonist, aspirin, and a P2Y12 receptor inhibitor (27,242,243).”
- Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction. (2017, neutral): “29 Mechanical ventilation Patients treated, n/n (%) 25/25 (100) 23/23 (100) Duration (days since device placement) 4 [3-13] 4 [2-8] 0.”
- 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2016, methodology): “The recommended minimum duration of DAPT in patients treated with first-generation DES, based primarily on observational data and one subgroup analysis, has been 12 months (9,51,97,104,105).”
- 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013, methodology): “Invasive coronary angiography should be used in accordance with the ACCF/AHA coronary artery bypass graft (CABG) and percutaneous coronary intervention guidelines (10,12) and should only be performed in patients who are potentially eligible for revascularization (307–309).”